Skip to main content

Table 3 Baseline characteristics

From: Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan

Baseline characteristics Ceftriaxone + standard care Standard care
Age - years   
Male sex - % n/N   
Medical history - % n/N   
- Atrial fibrillation/flutter   
- Stroke   
- Hypercholesterolemia   
- Hypertension   
- Myocardial infarction   
- Cardiac valve insufficiency/stenosis/replacement   
- Peripheral vascular disease   
- Obstructive pulmonary disease   
- Immunocompromised   
Current smoker - % n/N   
Medication prior to stroke - % n/N   
- Anticoagulants   
- Antiplatelet   
- Statin   
- ACE inhibitor   
- Bèta-blocker   
- Proton pump inhibitor   
Disability prior to stroke - mRS *   
Stroke severity - NIHSS **   
Swallowing screening performed - % n/N   
Dysphagic patients - % n/N   
Acute treatment - % n/N   
- IV thrombolysis   
- Coagulant therapy   
Diagnosis at discharge - % n/N   
- Infarction   
- Hemorrhage   
- Transient ischemic attack (TIA)   
- Other   
  1. *mRS, denotes modified Rankin Scale.
  2. **NIHSS denotes National Institutes of Health Stroke Scale.